文献速递免疫规划职业卫生

日本医学生与牙学生三剂乙肝疫苗接种后抗-HBs抗体获得率研究

Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
PubMed 文献 · Vaccine · 2018-11-16

本研究纳入832名已接种三剂乙肝疫苗的医学生与牙学生,其中491名纳入分析。结果显示第三剂前、第三剂后1个月和5个月抗-HBs阳性率分别为47.9%、95.9%和89.0%;1个月与5个月抗体滴度关系为log10y=log10x-0.134(P<0.0001)。

要点

  • 第三剂后1个月抗-HBs阳性率达95.9%,5个月降至89.0%。
  • 第三剂后1至5个月间抗-HBs滴度平均下降约20%。

核心结论

  • 第三剂乙肝疫苗后1至5个月抗-HBs滴度平均下降约20%,应定期监测抗-HBs。
  • 无应答者按与基础免疫相同程序接种三剂加强针可有效获得保护性抗-HBs滴度。

研究设计与样本

  • 研究对象为832名已接种三剂乙肝疫苗(Bimmugen® 0.5 ml/瓶)的医学生与牙学生,491名纳入分析,其中58.9%(289名)为男性。
  • 采用CLIA法在第三剂前及第三剂后1个月、5个月检测抗-HBs,以10 mIU/mL为获得阈值;对无应答者给予最多三剂加强针后复测抗-HBs滴度。

主要发现

  • 第三剂前、第三剂后1个月和5个月抗-HBs阳性率分别为47.9%、95.9%和89.0%。
  • 第三剂后1个月(x)与5个月(y)抗体滴度关系为log10y=log10x-0.134(P<0.0001)。

关键数值与推荐

  • 抗-HBs获得阈值定为10 mIU/mL。
  • 第三剂后1个月与5个月抗体滴度对数关系为log10y=log10x-0.134(P<0.0001)。
  • 无应答者加强免疫最多三剂,采用与基础免疫相同程序。

临床怎么用

  • 完成三剂乙肝疫苗后应定期检测抗-HBs滴度,关注1至5个月间的下降趋势。
  • 对无应答者可按与基础免疫相同程序接种三剂加强针以诱导保护性抗体。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Health care workers (HCWs) are at high risk of contracting blood-borne infections including hepatitis B virus (HBV) infection. In Japan, all HCWs are required to receive HB vaccination before beginning work. This study aimed to investigate the dynamics of the HB surface antibody (anti-HBs) titer after a three-dose HB vaccination in HCWs and to determine effective scheduling of HB vaccination for non-responders. METHODS: Subjects included 832 medical and dental students who had received a three-dose HB vaccination (Bimmugen® 0.5 ml/vial). Anti-HBs was measured three times (before the third dose and 1 and 5 months after the third dose) using the CLIA method. The cut-off value of anti-HBs acquisition was 10 mIU/mL. After booster doses (three maximum) were administered to non-responders, the anti-HBs titers were measured again. RESULTS: Out of 832 students, 491 were analyzed, of which 58.9% (289) were male. Anti-HBs-positive rates before the third dose and 1 and 5 months later were 47.9%, 95.9%, and 89.0%, respectively. The relationship between the antibody titer at one month (x) and 5 months (y) was estimated by log10y = log10x - 0.134 (P < 0.0001). Twelve non-responders were followed-up, all of which acquired a protective anti-HBs titer after revaccination with a three-dose booster. CONCLUSION: Anti-HBs titer decreases by an average of 20% within 4 months between the 1st and 5th month after the third dose. Therefore, anti-HBs titer should be measured periodically after completing the three-dose vaccination. Additionally, results suggested that booster doses are effective if administered with the same schedule as primary vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nagashima S, Yamamoto C, Ko K, et al. Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination. Vaccine. 2018. PMID: 30449632. doi:10.1016/j.vaccine.2018.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。